The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease

被引:164
|
作者
Cheng, Ying [1 ]
Bai, Feng [2 ]
机构
[1] Southeast Univ, Sch Med, Affiliated ZhongDa Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Univ, Med Sch, Drum Tower Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China
来源
FRONTIERS IN NEUROSCIENCE | 2018年 / 12卷
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; tau; mitochondrial transport; mitochondrial dynamics; mitochondrial dysfunction; AXONAL-TRANSPORT DEFECTS; OXIDATIVE STRESS; PHOSPHORYLATED TAU; AMYLOID-BETA; NEURODEGENERATIVE DISEASES; HYPERPHOSPHORYLATED TAU; SYNAPTIC DYSFUNCTION; ABNORMAL INTERACTION; MOUSE MODEL; PROTEIN-TAU;
D O I
10.3389/fnins.2018.00163
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Increasing evidence suggests that abnormally hyperphosphorylated tau plays a vital role in the pathogenesis of Alzheimer's disease (AD). Mitochondrial dysfunction also has a recognized role in the pathophysiology of AD. In recent years, mitochondrial dysfunction has been strongly associated with tau pathology in AD. Overexpression of hyperphosphorylated and aggregated tau appears to damage the axonal transport, leading to abnormal mitochondrial distribution. In addition, pathological tau impairs mitochondrial dynamics by regulating mitochondrial fission/fusion proteins, and further causes mitochondrial dysfunction and neuronal damage. Moreover, mitochondrial dysfunction is also involved in promoting tau pathology in AD. In this article, we evaluate the relationship between phosphorylated tau and mitochondrial dysfunction in AD.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer's disease
    Kim, Dong Kyu
    Mook-Jung, Inhee
    BMB REPORTS, 2019, 52 (12) : 679 - 688
  • [2] Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations
    Li, Ke
    Wei, Qing
    Liu, Fang-Fang
    Hu, Fan
    Xie, Ao-ji
    Zhu, Ling-Qiang
    Liu, Dan
    MOLECULAR NEUROBIOLOGY, 2018, 55 (04) : 3021 - 3032
  • [3] Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer's Disease
    Rai, Sachchida Nand
    Singh, Charan
    Singh, Arti
    Singh, M. P.
    Singh, Brijesh Kumar
    MOLECULAR NEUROBIOLOGY, 2020, 57 (07) : 3075 - 3088
  • [4] The complexity of tau in Alzheimer's disease
    Naseri, Nima N.
    Wang, Hong
    Guo, Jennifer
    Sharma, Manu
    Luo, Wenjie
    NEUROSCIENCE LETTERS, 2019, 705 : 183 - 194
  • [5] Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks
    Correia, Sonia C.
    Perry, George
    Moreira, Paula I.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2016, 1862 (10): : 1909 - 1917
  • [6] The Role of Mitochondrial Impairment in Alzheimer's Disease Neurode-generation: The Tau Connection
    Quntanilla, Rodrigo A.
    Tapia-Monsalves, Carola
    CURRENT NEUROPHARMACOLOGY, 2020, 18 (11) : 1076 - 1091
  • [7] An update on the association between traumatic brain injury and Alzheimer's disease: Focus on Tau pathology and synaptic dysfunction
    Li, Liangping
    Liang, Jiawen
    Fu, Hongjun
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2021, 120 : 372 - 386
  • [8] Mitochondrial dysfunction and Alzheimer's disease: prospects for therapeutic intervention
    Lim, Ji Woong
    Lee, Jiyoun
    Pae, Ae Nim
    BMB REPORTS, 2020, 53 (01) : 47 - 55
  • [9] Mitochondrial Dysfunction in Alzheimer's Disease: Opportunities for Drug Development
    Bhatia, Shiveena
    Rawal, Rishi
    Sharma, Pratibha
    Singh, Tanveer
    Singh, Manjinder
    Singh, Varinder
    CURRENT NEUROPHARMACOLOGY, 2022, 20 (04) : 675 - 692
  • [10] Alzheimer's Disease and Parkinson's Disease: A Nutritional Toxicology Perspective of the Impact of Oxidative Stress, Mitochondrial Dysfunction, Nutrigenomics and Environmental Chemicals
    Agnihotri, Aayushi
    Aruoma, Okezie I.
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2020, 39 (01) : 16 - 27